<page><title>ADNP syndrome</title><url>https://medlineplus.gov/genetics/condition/adnp-syndrome</url><content>ADNP syndrome
To use the sharing features on this page, please enable JavaScript.
Description
ADNP
syndrome is a condition that causes a wide variety of signs and symptoms. Its hallmark features are intellectual disability and
autism spectrum disorder
, which is characterized by impaired communication and social interaction. Affected individuals also have distinctive facial features and abnormalities of multiple body systems.
Individuals with
ADNP
syndrome have mild to severe intellectual disability and delayed development of speech and motor skills such as sitting and walking. Some affected individuals are never able to speak. People with this disorder exhibit characteristics typical of autism spectrum disorder, including repetitive behaviors and difficulty with social interactions.
ADNP
syndrome is also associated with mood disorders or behavioral problems, such as anxiety, temper tantrums,
attention-deficit/hyperactivity disorder
(ADHD),
obsessive-compulsive disorder
, or sleep problems.
Many people with
ADNP
syndrome have distinctive facial features, which most commonly include a prominent forehead, a high hairline, outside corners of the eyes that point upward or downward (upslanting or downslanting palpebral fissures), droopy eyelids (ptosis), a broad nasal bridge, and a thin upper lip. These individuals may also have unusually shaped ears or hand and finger abnormalities. Eye and vision abnormalities, such as eyes that do not point in the same direction (strabismus) and
farsightedness
(
hyperopia
), also occur in
ADNP
syndrome. Some people with this condition have early appearance (eruption) of primary (baby) teeth.
Some people with
ADNP
syndrome have weak muscle tone (hypotonia) and feeding difficulties in infancy. They may also have digestive system problems, such as backflow of stomach acids into the esophagus (
gastroesophageal reflux
), vomiting, and constipation. Other features that occur in
ADNP
syndrome include obesity, seizures, and heart abnormalities.
Frequency
The prevalence of
ADNP
syndrome is unknown. It is estimated to account for 0.17 percent of all cases of autism spectrum disorder, making it one of the most common genetic causes of this condition.
Causes
ADNP
syndrome is caused by mutations in the
ADNP
gene. The protein produced from this gene helps control the activity (expression) of other genes through a process called chromatin remodeling.
Chromatin
is the network of DNA and protein that packages DNA into chromosomes. The structure of chromatin can be changed (remodeled) to alter how tightly DNA is packaged. Chromatin remodeling is one way gene expression is regulated during development; when DNA is tightly packed, gene expression is lower than when DNA is loosely packed.
By regulating gene expression, the ADNP protein is involved in many aspects of growth and development. It is particularly important for regulation of genes involved in normal brain development, and it likely controls the activity of genes that direct the development and function of other body systems.
Although it is unclear how mutations in the
ADNP
gene affect ADNP protein function, researchers suggest that the mutations result in abnormal chromatin remodeling. Disturbance of this process alters the activity of many genes and disrupts development or function of several of the body's tissues and organs, including the brain. These changes likely explain the intellectual disability, autism spectrum disorder, and other diverse signs and symptoms of
ADNP
syndrome.
Learn more about the gene associated with ADNP syndrome
ADNP
Inheritance
ADNP
syndrome is not inherited. It results from new (
de novo
) mutations in the
ADNP
gene that occur during the formation of reproductive cells (eggs or sperm) or in early embryonic development. The condition occurs in people with no history of the disorder in their family.
Other Names for This Condition
ADNP-related intellectual disability and autism spectrum disorder
ADNP-related multiple congenital anomalies-intellectual disability-autism spectrum disorder
Helsmoortel-van der Aa syndrome
HVDAS
Mental retardation, autosomal dominant 28
MRD28
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
Genetic and Rare Diseases Information Center
ADNP syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
HELSMOORTEL-VAN DER AA SYNDROME; HVDAS
Scientific Articles on PubMed
PubMed
References
Gozes I, Van Dijck A, Hacohen-Kleiman G, Grigg I, Karmon G, Giladi E, Eger M,
Gabet Y, Pasmanik-Chor M, Cappuyns E, Elpeleg O, Kooy RF, Bedrosian-Sermone S.
Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated
children. Transl Psychiatry. 2017 Feb 21;7(2):e1043. doi: 10.1038/tp.2017.27.
Erratum In: Transl Psychiatry. 2017 Jul 4;7(7):e1166. doi: 10.1038/tp.2017.128.
Citation on PubMed
Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, van den
Ende J, Schuurs-Hoeijmakers JH, Marcelis CL, Willemsen MH, Vissers LE, Yntema HG,
Bakshi M, Wilson M, Witherspoon KT, Malmgren H, Nordgren A, Anneren G, Fichera M,
Bosco P, Romano C, de Vries BB, Kleefstra T, Kooy RF, Eichler EE, Van der Aa N. A
SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet.
2014 Apr;46(4):380-4. doi: 10.1038/ng.2899. Epub 2014 Feb 16.
Citation on PubMed
or
Free article on PubMed Central
Krajewska-Walasek M, Jurkiewicz D, Piekutowska-Abramczuk D, Kucharczyk M,
Chrzanowska KH, Jezela-Stanek A, Ciara E. Additional data on the clinical
phenotype of Helsmoortel-Van der Aa syndrome associated with a novel truncating
mutation in ADNP gene. Am J Med Genet A. 2016 Jun;170(6):1647-50. doi:
10.1002/ajmg.a.37641. Epub 2016 Mar 31. No abstract available.
Citation on PubMed
Pescosolido MF, Schwede M, Johnson Harrison A, Schmidt M, Gamsiz ED, Chen WS,
Donahue JP, Shur N, Jerskey BA, Phornphutkul C, Morrow EM. Expansion of the
clinical phenotype associated with mutations in activity-dependent
neuroprotective protein. J Med Genet. 2014 Sep;51(9):587-9. doi:
10.1136/jmedgenet-2014-102444. Epub 2014 Jul 23. No abstract available.
Citation on PubMed
or
Free article on PubMed Central
Van Dijck A, Vandeweyer G, Kooy F. ADNP-Related Disorder. 2016 Apr 7
[updated 2022 Oct 6]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE,
Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet].
Seattle (WA): University of Washington, Seattle; 1993-2024. Available from
http://www.ncbi.nlm.nih.gov/books/NBK355518/
Citation on PubMed
Vandeweyer G, Helsmoortel C, Van Dijck A, Vulto-van Silfhout AT, Coe BP,
Bernier R, Gerdts J, Rooms L, van den Ende J, Bakshi M, Wilson M, Nordgren A,
Hendon LG, Abdulrahman OA, Romano C, de Vries BB, Kleefstra T, Eichler EE, Van
der Aa N, Kooy RF. The transcriptional regulator ADNP links the BAF (SWI/SNF)
complexes with autism. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):315-26.
doi: 10.1002/ajmg.c.31413. Epub 2014 Aug 28.
Citation on PubMed
or
Free article on PubMed Central
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>